{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-003523","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2022-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.330576+00:00","generated_at":"2026-06-27T05:47:47.890109+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Medifast Q4 revenue $377.8M (+42.6%); FY 2021 revenue $1.526B (+63.2%)","bullets":["Q4 diluted EPS $2.91 vs $2.36 YoY; net income $34.0M (+21.5%).","Active earning OPTA VIA Coaches up 35.3% to 59,800; revenue per coach $6,321.","FY 2022 guidance: revenue $1.72B-$1.79B; diluted EPS $14.50-$16.00.","Cash and investments $109.5M; no interest-bearing debt; $16.8M dividend paid Feb 8.","Repurchased $56M of stock in FY 2021; $10M in Q4 alone."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-003523","json":"https://secwatch.observer/filing/0001628280-22-003523.json","markdown":"https://secwatch.observer/filing/0001628280-22-003523.md","text":"https://secwatch.observer/filing/0001628280-22-003523.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828022003523/0001628280-22-003523-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828022003523/med-20220223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:47:47.890109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}